A Melanoma Drug Successfully Launched, Yet Iovance’s Stock Has Underperformed the Market for Three Years Apr 10, 2026 Life Science
How Should Investors Position Themselves in This Year’s S&P 500 “Dark Horses” Moderna and Target? Apr 9, 2026 Consumer Goods, Life Science
Seeking Opportunities Amid U.S. Stock Market Volatility, These Two Healthcare Stocks Are Both Cheap and High-Yielding Apr 9, 2026 Life Science
Faced with Aggression from Medtronic and Johnson & Johnson, How Does Intuitive Surgical Defend Its Monopoly? Apr 8, 2026 Life Science
Eli Lilly Writes a Check. AC Immune Surges 15%. Is This Strategy or Spare Change? Apr 7, 2026 Life Science
Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise Apr 1, 2026 Life Science
Impressive Performance Yet Low Stock Price, Can Eli Lilly Usher in a Turning Point with Medicare Coverage? Mar 31, 2026 Life Science
